Because adiponectin exerts a potent insulin-sensitizing effect by promoting the activation of AMP-activated protein kinase and PPARα in the liver and skeletal muscle, adiponectin may be a novel and promising therapeutic strategy for type 2 diabetes [20]. The gene discussed is PPARA; the disease is type 2 diabetes mellitus.